ASCENT Trademark

Trademark Overview

On Monday, August 24, 2020, a trademark application was filed for ASCENT with the United States Patent and Trademark Office. The USPTO has given the ASCENT trademark a serial number of 90133732. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Friday, December 6, 2024. This trademark is owned by RegenxBio Inc.. The ASCENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others, all the above for gene therapy, namely for use in the treatment of wet age-related macular degeneration (AMD) using subretinal delivery

General Information

Serial Number90133732
Word MarkASCENT
Filing DateMonday, August 24, 2020
Status760 - EX PARTE APPEAL PENDING
Status DateFriday, December 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others, all the above for gene therapy, namely for use in the treatment of wet age-related macular degeneration (AMD) using subretinal delivery

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 26, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegenxBio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, August 27, 2020NEW APPLICATION ENTERED
Saturday, September 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 19, 2020ASSIGNED TO EXAMINER
Saturday, December 19, 2020SUSPENSION LETTER WRITTEN
Saturday, December 19, 2020LETTER OF SUSPENSION E-MAILED
Saturday, December 19, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 22, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 8, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 20, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 12, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 19, 2024NON-FINAL ACTION WRITTEN
Friday, January 19, 2024NON-FINAL ACTION E-MAILED
Friday, January 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 6, 2024FINAL REFUSAL E-MAILED
Thursday, June 6, 2024FINAL REFUSAL WRITTEN
Friday, July 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 6, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, December 6, 2024EXPARTE APPEAL RECEIVED AT TTAB
Friday, December 6, 2024EX PARTE APPEAL-INSTITUTED
Friday, December 6, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY

Related Keywords

ascent trials namely research clinical scientific medical macular related degeneration using